Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4275238 | 0.85 | ALDH1A1 (0.42) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL8311646 | 0.83 | PTGDR2 (0.37) | LMNANPC1GAATSHRALDH1A1 | |
| SCHEMBL12347952 | 0.81 | ALDH1A1 (0.40) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL23254247 | 0.79 | ALDH1A1 (0.42) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL158497 | 0.77 | TSHR (0.55) | LMNAGAATSHRALDH1A1MEN1 | |
| SCHEMBL21722426 | 0.76 | CHRNB2 (0.41) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL21664800 | 0.76 | CYP1A2 (0.45) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL2980367 | 0.76 | CYP1A2 (0.42) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL4614113 | 0.76 | CYP1A2 (0.36) | CYP1A2CHRM2CHRM4CHRM5CYP2D6 | |
| SCHEMBL4817856 | 0.76 | TSHR (0.59) | CYP1A2LMNATSHRALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11081729-B2 | Non-aqueous electrolyte solution additive, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same | LG CHEM, LTD. | 2021-08-03 | — | — | US | disclosed |
| US-20200044287-A1 | Non-aqueous Electrolyte Solution Additive, and Non-aqueous Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery which Include the Same | LG CHEM, LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
| EP-3518334-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE, NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY, COMPRISING NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE | LG Chem, Ltd. (KR) | 2019-07-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200044287-A1 | Non-aqueous Electrolyte Solution Additive, and Non-aqueous Electrolyte Solution for Lithium Secondary Battery and Lithium Secondary Battery which Include the Same | LAGE3, KCNN2, CACNA1F | CYP1A2 4366/4885CHRM2 1410/4885CHRM4 2358/4885 |
| US-11081729-B2 | Non-aqueous electrolyte solution additive, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same | LAGE3, KCNN2, CACNA1F | CYP1A2 4366/4885CHRM2 1410/4885CHRM4 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.